Navigation Links
Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
Date:1/28/2009

he Phase 3 clinical studies were completed in October 2007 and the BLA was filed with the FDA in October 2008. Savient has exclusively licensed worldwide rights to the technology related to pegloticase, formerly referred to as Puricase(R), from Duke University and Mountain View Pharmaceuticals, Inc. Savient's experienced management team is committed to advancing its pipeline and expanding its product portfolio by in-licensing late-stage compounds and exploring co-promotion and co-development opportunities that fit the Company's expertise in specialty pharmaceuticals and biopharmaceuticals with an initial focus in rheumatology. Savient also manufactures and supplies Oxandrin(R) (oxandrolone tablets, USP) CIII in the U.S. Puricase is a registered trademark of Mountain View Pharmaceuticals, Inc. Further information on Savient can be accessed by visiting: http://www.savient.com.

FORWARD-LOOKING LANGUAGE

All statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions help identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding the efficacy and safety of pegloticase, our BLA filing with the FDA, the Advisory Committee, approval of the BLA, preparation for commercialization of pegloticase, and the market for pegloticase, are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and inte
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Mass. , Sept. 3, 2015 ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that its President and Chief Executive Officer, ... the 2015 Wells Fargo Healthcare Conference at 8:50 a.m. ... held Sept. 9-10, 2015 at The Hyatt Regency, ...
(Date:9/3/2015)... Calif. , Sept. 3, 2015  Four ... in a white paper released by Leaf ... Agency for Healthcare Research & Quality (AHRQ), ... estimated $9.1-$11.6 billion annually . In addition to ... in litigation, government penalties, and negatively impact hospital ...
(Date:9/3/2015)... 2015  Omeros Corporation (NASDAQ: OMER ) today ... Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, ... the District of New Jersey ... of Delaware . The lawsuits were ... three Omeros patents, U.S. Patent Nos. 8,173,707, 8,586,633 and ...
Breaking Medicine Technology:HeartWare Presentation At The 2015 Wells Fargo Healthcare Conference To Be Webcast 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4
... SAN DIEGO, Oct. 15 LifeVantage Corporation ... Protandim® and TrueScience(TM) Anti-Aging Cream, science-based solutions to oxidative ... fiscal quarter of 2010. The Company anticipates net revenue ... ended September 30, 2009, compared to net revenue of ...
... (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis ... the third quarter ended September 30, 2009 on Thursday, November ... , NxStage will also host a conference call at 9:00 ... its third quarter financial results. To listen to the conference ...
Cached Medicine Technology:LifeVantage Announces Preliminary Unaudited First Quarter Revenue 2LifeVantage Announces Preliminary Unaudited First Quarter Revenue 3LifeVantage Announces Preliminary Unaudited First Quarter Revenue 4NxStage(R) to Report Third Quarter 2009 Financial Results 2
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers ... settlements under the Stark physician self-referral law. “Stark Law DOs and DON’Ts: ... Atlantic Information Services, Inc. (AIS), will detail which deals are attracting the most ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... and medical assistance company today announced that it has entered into a multi-year ... EMED signed an agreement to bridge the link between American healthcare, Jamaican healthcare ...
(Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... While ... as to the best practices when preparing for a bariatric procedure, some patients have ... procedure. Apart from the basic instructions typical for many types of surgery that should ...
(Date:9/3/2015)... ... September 03, 2015 , ... NanoCytomics LLC today ... technology company that will bring low-cost cancer pre-screening tests to primary care physicians ... and automated technology platform detects and measures cellular changes at the nanoscale level. ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... Amerinet Inc., a leading national healthcare solutions organization, to provide electronic medical record ... Through this agreement, Amerinet members will receive negotiated pricing on E-Volve Health’s Epic ...
Breaking Medicine News(10 mins):Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2
... ... to help anyone seeking improved health and wellness. Learn how to improve the look and ... enhance your physical appearance with information provided on this new Web site. , ... (PRWEB) June 17, 2010 -- A new Web site has ...
... , ... to announce the addition of Lázaro Garza as an Engineered Sales Representative for Ellsworth Adhesives ... ... announce the addition of Lázaro Garza as an Engineered Sales Representative for Ellsworth Adhesives S. ...
... Italy, Thursday 17 June 2010: Smoking cigarettes is a ... may have a negative impact on the effectiveness of ... these treatments, according to results of two studies presented ... European League Against Rheumatism in Rome, Italy. A further ...
... ... in 2010 Focusing on Professional, Olympic, and Recreational Athletes , ... Washington, D.C. (PRWEB) June 17, 2010 -- Athletes for Hope ... Agassi, Muhammad Ali, and Lance Armstrong for the purpose of inspiring all athletes to engage ...
... ... Receives Seal of Approval from Industry Voice , ... Fishkill, NY (PRWEB) June 17, 2010 -- Dear ... dentistry and oral health, has announced that the International Congress of Oral Implantologists ...
... ... released Semantics Platform v 2.0 which is made up of three products: Semantics.Datacenter, Semantics.Server, ... product offerings in industry standard benchmark tests (Berlin 100M 5/25/10). , ... Brattleboro, VT (PRWEB) June ...
Cached Medicine News:Health News:New Web Site Provides Helpful Exercise and Nutrition Tips 2Health News:Ellsworth Adhesives Announces New International Engineered Sales Representative 2Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 2Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 3Health News:Athletes for Hope Awarded $2 Million Grant by Kellogg Foundation 2Health News:Athletes for Hope Awarded $2 Million Grant by Kellogg Foundation 3Health News:International Congress of Oral Implantologists (ICOI) Joins Other Professional Organizations Endorsing Dear Doctor Magazine 2Health News:Intellidimension Releases New Version of Semantic Web Technologies 2
... Helps eliminate the use of sand bags under the ... is dome shaped for optimal foot contact and positioning ... unit can be used under the drape by attaching ... be sterilized for use on top of the drape. ...
Helps support the femur during femoral fracture fixation and extremity prepping....
Helps protect the chest and shoulders from slumping forward during total hip surgery....
... M3-X Extremity Fixation System is a rigid fixation ... It offers modular instrumentation and a superior ... M3-X features four sizes of true lag ... and foot. OSTEOMED's lag screw design eliminates ...
Medicine Products: